Light-Induced Functionalization of Amphiphilic Block Copolymers: Application to Nanoparticles for Drug Targeting

Abstract:

Photografting of bifunctional photolinker on biocompatible amphiphilic copolymers, such as PCL-b-PEGs and PLGA-b-PEGs, has been developed as a practical and versatile strategy for the materials functionalisation. Depending on the copolymer nature (block length, % of crystallinity) and the experimental conditions we could selectively direct the grafting on the hydrophilic PEG segments. The resulting copolymers were further derivatized with molecules of interest (RGD-peptides, LDV-peptides, “home-made”peptidomimetics, mannose derivatives,…) by substitution of the O-succinimidyl ester of the photolinker. The derivatization rates were controlled by radiolabelling, colorimetric assay and XPS spectroscopy. The functionalized copolymers were used in the formulation of nanoparticles displaying the ligands on their outer-shell. This nanoparticulate system was successfully employed for the oral vectorisation of antigen and for the targeted delivery of an anticancer drug.

• Periodical: Materials Science Forum (Volumes 636-637)
• Pages: 759-765
• DOI: https://doi.org/10.4028/www.scientific.net/MSF.636-637.759
• Online since: January 2010
• Authors: Vincent Pourcelle, Jacqueline Marchand-Brynaert
• Keywords: Amphiphilic Block Copolymer, Aryl Azide, Covalent Immobilization, Integrin Ligand, LSC, Nanoparticle, Photografting, XPS

References

[1] W.E. Bawarski, E. Chidlowsky, D.J. Bharali and S.A. Mousa: Nanomed. Nanotechnol. Biol. Med. Vol. 4 (2008), p.273.

[2] A. des Rieux, V. Fievez, M. Garinot, Y. -J. Schneider and V. Preat: J. Controlled Release Vol. 116 (2006), p.1.

[3] K. Van Butsele, R. Jerome and C. Jerome: Polymer Vol. 48 (2007), p.7431.

[4] L. Juillerat-Jeanneret: Drug Discovery Today Vol. 13 (2008), p.1099.

[5] Y.B. Patil, U.S. Toti, A. Khdair, L. Ma and J. Panyam: Biomaterials Vol. 30 (2009), p.859.

[6] S. Devouge, C. Salvagnini and J. Marchand-Brynaert: Bioorg. Med. Chem. Lett. Vol. 15 (2005), p.3252.

[7] C. Salvagnini, A. Roback, M. Momtaz, V. Pourcelle and J. Marchand-Brynaert: J. Biomater. Sci., Polym. Ed. Vol. 18 (2007), p.1491.

[8] C. Salvagnini and J. Marchand Brynaert: Adv. Mat. Forum III Vol. 514 - 516 (2006), p.961.

[9] S. Devouge, J. Conti, A. Goldsztein, E. Gosselin, A. Brans, M. Voué, J. De Coninck, F. Homblé, E. Goormaghtigh and J. Marchand-Brynaert: J. Colloid Interface Sci. Vol. 332 (2009), p.408.

DOI: 10.1016/j.jcis.2008.12.045

[10] V. Pourcelle, S. Devouge, M. Garinot, V. Preat and J. Marchand-Brynaert: Biomacromolecules Vol. 8 (2007), p.3977.

DOI: 10.1021/bm700841y

[11] V. Pourcelle, H. Freichels, F. Stoffelbach, R. Auzély-Velty, C. Jérôme and J. MarchandBrynaert: Biomacromolecules Vol. 10 (2009), p.966.

DOI: 10.1021/bm900027r

[12] M. Garinot, V. Fievez, V. Pourcelle, F. Stoffelbach, A. des Rieux, L. Plapied, I. Theate, H. Freichels, C. Jerome, J. Marchand-Brynaert, Y. -J. Schneider and V. Preat: J. Controlled Release Vol. 120 (2007), p.195.

DOI: 10.1016/j.jconrel.2007.04.021

[13] V. Fievez, L. Plapied, A. des Rieux, V. Pourcelle, H. Freichels, V. Wascotte, M. -L. Vanderhaeghen, C. Jerôme, A. Vanderplasschen, J. Marchand-Brynaert, Y. -J. Schneider and V. Préat: Eur. J. Pharm. Biopharm. Vol. 73 (2009), p.16.

DOI: 10.1016/j.ejpb.2009.04.009

[14] F. Danhier, B. Vroman, N. Lecouturier, N. Crokart, V. Pourcelle, H. Freichels, C. Jérôme, J. Marchand-Brynaert, O. Feron and V. Préat: J. Controlled Release Vol. In Press.

DOI: 10.1016/j.jconrel.2009.08.011

[15] M. Momtaz, V. Rerat, S. Gharbi, E. Gerard, V. Pourcelle and J. Marchand-Brynaert: Bioorg. Med. Chem. Lett. Vol. 18 (2008), p.1084.

[16] V. Rerat: PhD Thesis, Université catholique de Louvain (2008), 421p.

[17] T. Chung, Y. Lu, S. Wang, Y. Lin and S. Chu: Biomaterials Vol. 23 (2002), 4803.

[18] A. Reiser, L.J. Leyshon and L. Johnston: Trans. Faraday Soc. Vol. 67 (1971), 2389.

[19] R.O. Hynes: Vol. 110 (2002), 673.